[Symposium on treatment of cancer. 1. Chemotherapy of acute leukemia in adults].
D015250:Aclarubicin; D000208:Acute Disease; D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004317:Doxorubicin / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D007938:Leukemia / Q000188:drug therapy*; D008875:Middle Aged; D009279:Naphthacenes / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D007370:Interferon Type I; D009279:Naphthacenes; D003561:Cytarabine; C047643:N(4)-palmitoyl cytarabine; D015250:Aclarubicin; D004317:Doxorubicin; C015019:enocitabine; C027260:pirarubicin